How To Outsmart Your Boss ADHD Medication Pregnancy > 자유게시판

• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

Women suffering from ADHD have to make a difficult choice on whether to keep or stop taking ADHD medication during pregnancy and breastfeeding. There aren't enough data regarding how exposure over time may affect a fetus.

A study recently published in Molecular Psychiatry demonstrates that children exposed to ADHD medication during pregnancy do not develop neurological problems such as hearing loss or vision, febrile seizures or IQ impairment. The authors acknowledge that more high-quality studies are needed.

Risk/Benefit Analysis

Women who are pregnant and taking ADHD medications must weigh the advantages of taking them against the potential risks to the foetus. Physicians don't have the data to make unambiguous recommendations but they can provide information about risks and benefits to help pregnant women make informed choices.

A study published in Molecular Psychiatry found that women who used ADHD medications during their early pregnancy did not have an increased risk of fetal cardiac malformations or major structural birth defects. Researchers conducted a large sample-based case control study to examine the prevalence of structural defects that were major in infants born to mothers who were taking stimulants during pregnancy. Clinical geneticists and pediatric cardiologists examined the cases to ensure an accurate classification of the cases and to reduce the possibility of bias.

However, the researchers' study had its limitations. The researchers were unable in the beginning to differentiate the effects of the medication from the disorder. This limitation makes it difficult for researchers to establish whether the small associations observed among the exposed groups were due to the use of medications or if they were affected by co-morbidities. Additionally the researchers did not study the long-term outcomes of offspring.

The study revealed that infants whose mother had taken ADHD medication during pregnancy had a slightly greater risk of being admitted to the neonatal care unit (NICU) in comparison to mothers who did not use any medication during pregnancy or had stopped taking their medication before or during pregnancy. This was due to central nervous system disorders. The increased risk of admission was not influenced by the stimulant medication used during pregnancy.

Women who took stimulant ADHD medications during pregnancy also had a higher risk of having to have caesarean sections or the baby was not scoring well on the Apgar scale (less than 7). These increases did appear to be independent of the type of medication used during pregnancy.

The research suggests that the small risk associated with the use of ADHD medications during the early stages of pregnancy may be offset by the greater benefits for both mother and child of continuing treatment for the woman's condition. Physicians should discuss this with their patients and, when they are able, assist them in developing strategies to improve their coping abilities which can i get adhd medication without a diagnosis reduce the negative impact of her condition on her daily life and relationships.

Medication Interactions

As more women than ever before are being diagnosed with ADHD and being treated with medication, the question of whether or not to end treatment during pregnancy is a question that doctors are having to have to face. Often, these decisions are made in the absence of any evidence that is clear and definitive either way, so physicians have to weigh their experience about their experiences, the experiences of other doctors, and what medications are prescribed for adhd research suggests about the subject, along with their best judgment for each patient.

The issue of risk for infants can be extremely difficult. Many studies on this issue are based on observational data rather than controlled research and their findings are often contradictory. Additionally, the majority of studies limit their analysis to live births, which may underestimate the severity of teratogenic effects that could cause abortion or termination of the pregnancy. The study discussed in the journal club addresses these limitations by analyzing data on live and deceased births.

The conclusion: While certain studies have demonstrated that there is a positive correlation between ADHD medications and the possibility of certain birth defects, others have found no connection, and most studies have a neutral or slight negative effect. In all cases an in-depth study of the risks and benefits should be conducted.

For women suffering from buy adhd medication online who suffer from ADHD, the decision to stop medication is difficult, if not impossible. In an article recently published in Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation, and family conflict for these patients. Furthermore, a loss of medication can affect the ability to complete jobs and drive safely which are essential aspects of a normal life for a lot of people with ADHD.

She recommends women who are uncertain about whether to continue or stop taking medication because of their pregnancy consider informing family members, friends and colleagues about the condition, its effects on daily life, and the advantages of staying on the current treatment plan. In addition, educating them can aid in ensuring that the woman feels supported as she struggles with her decision. Certain medications can pass through the placenta. If the patient decides not to take her ADHD medication for adhd and bipolar while pregnant and breastfeeding, it's important to be aware that the medication could be transferred to the infant.

Risk of Birth Defects

As the use and misuse of ADHD medication to treat symptoms of attention deficit hyperactivity disorder (ADHD) increases the concern over the potential effects of these drugs on the fetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this issue. Utilizing two huge data sets, researchers were able to examine more than 4.3 million pregnancies and see whether stimulant medications increased the risk of birth defects. Researchers discovered that although the risk overall is low, first-trimester ADHD medication use was associated with slightly higher risk of specific heart defects like ventriculoseptal defects.

The researchers behind the study found no association between the use of early medications and congenital abnormalities like facial clefting, or club foot. The findings are in line with previous studies showing a small but significant increase in the risk of heart malformations among women who began taking ADHD medications before the birth of their child. This risk increased during the latter part of pregnancy, as many women are forced to stop taking their ADHD medication.

Women who took ADHD medications during the first trimester of their pregnancy were also more likely to have caesarean sections, a low Apgar score after delivery and a baby that required help breathing at birth. The authors of the study could not eliminate bias due to selection because they limited the study to women who did not have any other medical conditions that could have contributed to the findings.

Researchers hope their research will provide doctors with information when they meet pregnant women. They advise that while a discussion of risks and benefits is important but the decision to stop or maintain treatment must be based on each woman's needs and the severity of her ADHD symptoms.

The authors also caution that while discontinuing the medications is an alternative, it is not a recommended practice because of the high incidence of depression and other mental health issues for women who are expecting or who are recently post-partum. Additionally, research suggests that women who stop taking their medication will have a harder adjustment to life without them after the baby is born.

Nursing

The responsibilities that come with being a new mother can be overwhelming. Women with ADHD who have to manage their symptoms while attending doctor appointments, making preparations for the arrival of a child and adapting to new routines in the home may face a lot of challenges. As such, many women choose to continue taking their ADHD medication throughout the pregnancy.

The risk for breastfeeding infant is minimal because the majority of stimulant medication is absorbed through breast milk in low amounts. However, the rate of medication exposure to the newborn may differ based on dosage, how often it is administered, and the time of day it is administered. In addition, various medications enter the baby’s system through the gastrointestinal tract or through breast milk. The impact on the health of a newborn is not completely understood.

Some physicians may discontinue stimulant medication during a woman’s pregnancy due to the lack of research. This is a difficult decision for the patient, who must weigh the benefits of keeping her medication with the potential risks to the fetus. Until more information is available, doctors should inquire with all pregnant patients about their history of ADHD and if they plan or are taking to take medication during the perinatal time.

A increasing number of studies have proven that women can continue to take their ADHD medication during pregnancy and while breastfeeding. In response, a growing number of patients are choosing to do so. They have concluded after consulting with their physicians, that the benefits of continuing their current medication outweigh any possible risks.

Women who suffer from ADHD who are planning to nurse should seek the advice of a specialist psychiatrist prior to becoming pregnant. They should discuss their medication with their doctor, and the pros and cons for continuing treatment. This includes non-pharmacological methods. Psychoeducation should also be offered to help women with ADHD recognize their symptoms and underlying disorder and learn about treatment options and reinforce existing strategies for coping. This should be a multidisciplinary effort including obstetricians, GPs and psychiatrists. Pregnancy counseling should consist of a discussion of a treatment plan for the mother and child, as well as monitoring for signs of deterioration, and, if needed adjustments to the medication regimen.